• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,867.80 -141.90
( -0.19%)
Global Indices
Nasdaq
50,669.84 187.16
(0.37%)
Dow Jones
7,541.62 1.50
(0.02%)
Hang Seng
65,194.32 198.23
(0.30%)
Nikkei 225
10,507.74 16.35
(0.16%)
Forex
USD-INR
95.57 0.31
(0.33%)
EUR-INR
111.17 0.28
(0.25%)
GBP-INR
128.70 0.16
(0.13%)
JPY-INR
0.60 0.00
(0.16%)

EQUITY - MARKET SCREENER

Rexpro Enterprises Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
93844
INE113601012
55.1477094
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REXPRO
6.15
49.31
EPS(TTM)
Face Value()
Div & Yield %
7.15
10
0
 

Aarti Drugs consolidated net profit declines 12.20% in the March 2026 quarter
May 16,2026
Net profit of Aarti Drugs declined 12.20% to Rs 55.19 crore in the quarter ended March 2026 as against Rs 62.86 crore during the previous quarter ended March 2025. Sales rose 6.43% to Rs 720.30 crore in the quarter ended March 2026 as against Rs 676.76 crore during the previous quarter ended March 2025.

For the full year,net profit rose 15.91% to Rs 194.92 crore in the year ended March 2026 as against Rs 168.16 crore during the previous year ended March 2025. Sales rose 7.47% to Rs 2565.31 crore in the year ended March 2026 as against Rs 2387.03 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales720.30676.76 6 2565.312387.03 7
OPM %13.3013.79 -12.0512.03 -
PBDT88.4086.04 3 277.87267.55 4
PBT70.3671.16 -1 210.90211.77 0
NP55.1962.86 -12 194.92168.16 16